An FDA committee voted unanimously June 5 on the 2024-2025 COVID-19 vaccine makeup, recommending it should be one that targets the monovalent JN.1-lineage vaccine.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Fall COVID shots poised for makeover
